World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
75
Citations
27051
World Ranking
19017
National Ranking
216

Kimmo Porkka publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Kimmo Porkka sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 447 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Kimmo Porkka D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Kimmo Porkka sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 75 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Kimmo Porkka is affiliated with the University of Helsinki in Finland and conducts research primarily within the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work focuses extensively on hematological malignancies and molecular biology, with significant contributions to Oncology and Immunology as well.

The scientist has published extensively on topics related to acute and chronic myeloid leukemias as well as multiple myeloma research and treatments. Their main research themes include:

  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Multiple Myeloma Research and Treatments
  • Histone Deacetylase Inhibitors Research
  • Cancer Genomics and Diagnostics
  • Acute Lymphoblastic Leukemia research

Porkka's publication record includes important papers such as:

  • "Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia," 2020, New England Journal of Medicine
  • "International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data," 2022, Blood
  • "Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission," 2020, New England Journal of Medicine
  • "Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia," 2021, Cancer Discovery
  • "Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia," 2024, American Journal of Hematology

The frequent venues where Porkka's work appears include:

  • Blood
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Lymphoma Myeloma & Leukemia
  • Leukemia
  • HemaSphere

Collaboration is a significant aspect of their research approach, with frequent co-authors being:

  • Mika Kontro
  • Caroline A. Heckman
  • Andrew H. Wei
  • Heikki Kuusanmäki
  • Krister Wennerberg

Kimmo Porkka's research contributes to advancing the understanding and treatment of hematological cancers by integrating clinical, morphologic, genomic, and functional precision medicine approaches within their studies.

Best Publications

  • Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

    Courtney D DiNardo;Brian A Jonas;Vinod Pullarkat;Michael J Thirman

  • Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia

    Hanna L.M. Koskela;Samuli Eldfors;Pekka Ellonen;Arjan J. van Adrichem

  • The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

    Camille Abboud;Ellin Berman;Adam Cohen

  • Effects of Persistent Physical Activity and Inactivity on Coronary Risk Factors in Children and Young Adults The Cardiovascular Risk in Young Finns Study

    O. T. Raitakari;K. V. K. Porkka;S. Taimela;R. Telama

  • A tumor-homing peptide with a targeting specificity related to lymphatic vessels

    Pirjo Laakkonen;Kimmo Porkka;Jason A Hoffman;Erkki Ruoslahti

  • Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score

    Joerg Hasford;Michele Baccarani;Verena Hoffmann;Joelle Guilhot

  • Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels

    Sven Christian;Jan Pilch;Maria E. Akerman;Maria E. Akerman;Kimmo Porkka;Kimmo Porkka

  • Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.

    Kimmo Porkka;Perttu Koskenvesa;Tuija Lundán;Johanna Rimpiläinen

  • Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet

    Simona Soverini;Andreas Hochhaus;Franck E. Nicolini;Franz Gruber

  • European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia

    J.L. Steegmann;M. Baccarani;M. Breccia;L.F. Casado

  • STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia

    Andres Jerez;Michael J. Clemente;Hideki Makishima;Hanna Koskela

  • Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia

    Tea Pemovska;Mika Kontro;Bhagwan Yadav;Henrik Edgren

  • A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo

    Kimmo Porkka;Pirjo Laakkonen;Jason A. Hoffman;Michele Bernasconi

  • Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies

    Bhagwan Yadav;Tea Pemovska;Agnieszka Szwajda;Evgeny Kulesskiy

  • Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy

    S. Mustjoki;M. Ekblom;T. P. Arstila;I. Dybedal

  • Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia

    Hanna L. M. Rajala;Samuli Eldfors;Heikki Kuusanmäki;Arjan J. van Adrichem

  • Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23

    Päivi Pajukanta;Ilpo Nuotio;Joseph D. Terwilliger;Kimmo V.K. Porkka

  • Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.

    Andrew H. Wei;Hartmut Döhner;Christopher Pocock;Pau Montesinos

  • Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma

    Jason A. Hoffman;Enrico Giraudo;Mallika Singh;Lianglin Zhang

  • Clonal Expansion of T/NK-Cells during Tyrosine Kinase Inhibitor Dasatinib Therapy

    Satu Mustjoki;Marja Ekblom;T. Petteri Arstila;Ingunn Dybedal

Frequent Co-Authors

Satu Mustjoki
Satu Mustjoki University of Helsinki
Olli Kallioniemi
Olli Kallioniemi Karolinska Institute
Bjørn Tore Gjertsen
Bjørn Tore Gjertsen Haukeland University Hospital
Tero Aittokallio
Tero Aittokallio University of Helsinki
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Jorma Viikari
Jorma Viikari Turku University Hospital
Andrew Wei
Andrew Wei Walter and Eliza Hall Institute of Medical Research
Michele Baccarani
Michele Baccarani University of Bologna
Olli T. Raitakari
Olli T. Raitakari Turku University Hospital
Janna Saarela
Janna Saarela University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn’t always mean becoming a physician. There are a variety of online health administration programs that offer skills in leadership, healthcare policy, and organization management. These programs open doors to roles in hospital administration or healthcare operations.

For registered nurses looking to expand their qualifications, rn to np bridge programs offer a streamlined pathway to becoming nurse practitioners. This progression can lead to advanced clinical roles and greater autonomy within healthcare teams.

Those with an interest in wellness and dietetics might consider online degrees in nutrition. These flexible degrees focus on food science, nutrition therapy, and behavior change, preparing graduates for careers in clinical settings or community health.

Ambitious students interested in healthcare management can also explore the cahme accredited online mha programs list. Earning a CAHME-accredited Master of Health Administration online is ideal for those wanting trusted credentials and the ability to move into executive leadership roles.

Best Scientists Citing Kimmo Porkka

Trending Scientists

Recently Published Articles